Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: KISS Study: Kinase Inhibition With Sprycel Start up [Phase 2]
A Phase 2 clinical trial update for a study evaluating Sprycel (dasatinib) in Chronic Myeloid Leukemia led by the University of Auckland; cu…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia [Phase 2]
Phase 2 trial updates the use of low-dose dasatinib (50 mg daily) as first-line treatment for newly diagnosed chronic-phase chronic myeloid …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Allo HSCT Using RIC for Hematological Diseases [Phase 2]
Phase 2 trial evaluating allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning for various hematologic dise…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II [Phase 1, Phase 2]
This Phase I/II clinical trial evaluated Interleukin-7 for T-cell recovery after haploidentical and cord blood stem cell transplantation and…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning [Phase 2]
Phase 2 trial update on allogeneic transplantation using timed sequential busulfan and fludarabine conditioning for various hematologic mali…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study [Phase 3]
A Phase 3 trial evaluating a tyrosine kinase inhibitor (TKI) with interferon alpha for chronic myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Dasatinib Holiday for Improved Tolerability [Phase 3]
A Phase 3 clinical trial update reports dasatinib holiday strategies to improve tolerability in chronic myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation [Phase 2]
A pivotal Phase 2 study evaluating HQP1351 in chronic myeloid leukemia in accelerated phase with T315I mutation; current status not provided…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing thymoglobulin to alemtuzumab in patients undergoing allogeneic stem cell transplantation has been compl…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) [Phase 2]
Phase 2 clinical trial update for the LAST study evaluating outcomes after stopping tyrosine kinase inhibitors in chronic myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Bosutinib in Elderly Chronic Myeloid Leukemia [Phase 2]
Phase 2 trial update for bosutinib in elderly patients with chronic myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention [Phase 3]
Phase 3 trial comparing Tacrolimus plus mini-methotrexate versus Tacrolimus plus methotrexate for graft-versus-host disease prevention has c…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia [Phase 2]
Phase 2 trial comparing imatinib or nilotinib with pegylated interferon-α2b in chronic myeloid leukemia; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation [Phase 3]
A Phase 3 randomized trial comparing Fludarabine and Busulfan versus Fludarabine, Busulfan plus Total Body Irradiation in patients with myel…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. [Phase 2]
Phase 2 trial update on conditioning regimens for transplantation of unrelated donor umbilical cord blood in patients with hematologic malig…
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies [Phase 2]
Phase 2 clinical trial update on shorter course tacrolimus after non-myeloablative conditioning with related donor PBSCT and high-dose postt…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS [Phase 3]
Phase 3 trial comparing NiCord (omidubicel) stem cell transplantation to standard umbilical cord blood in patients with hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow [Phase 2]
Phase 2 trial update on specialized blood cell transplants for cancers of the blood and bone marrow; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2) [Phase 2]
A multicenter single-arm Phase 2 pilot study evaluating the efficacy of nilotinib in chronic myeloid leukemia patients with molecular relaps…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP [Phase 4]
A Phase 4 trial update investigates using reduced-dose dasatinib (70 mg daily) as first-line treatment for newly diagnosed chronic myeloid l…
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline. [Phase 4]
Phase 4 clinical trial evaluating deep molecular response in adults with chronic-phase Chronic Myeloid Leukemia treated with nilotinib first…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]
Phase 1/2 trial update of ponatinib in Japanese patients with Chronic Myeloid Leukemia and Philadelphia chromosome-positive Acute Lymphoblas…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies [Phase 3]
Phase 3 clinical trial update on stem cell transplantation from partially HLA-m matched related donors for hematologic malignancies; trial c…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy [Phase 2]
Phase 2 trial investigating stem cell monitoring in chronic myeloid leukemia patients treated with nilotinib has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs [Phase 3]
A Phase 3 trial comparing ABL001 (asciminib) to bosutinib in chronic myeloid leukemia in chronic phase patients previously treated with ≥2 T…